A pragmatic, randomised, multicentre trial comparing 4-weekly vs. 12-weekly administration of bone-targeted agents (denosumab, zoledronate or pamidronate) in patients with bone metastases
Titel:
A pragmatic, randomised, multicentre trial comparing 4-weekly vs. 12-weekly administration of bone-targeted agents (denosumab, zoledronate or pamidronate) in patients with bone metastases
Auteur:
Clemons, M. Stober, C. Mates, M. Joy, A.A. Robinson, A. Hilton, J. Blanchette, P. Aseyev, O. Pond, G. Fergusson, D.